Physician profile
Bridget Winterhalter
NPI 1730614298
$2,049.46
in general payments reported to CMS, 2019-2025
10 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $527 · 2023: $710 · 2024: $410 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329 · Travel and Lodging: $39.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.77 |
| Travel and Lodging | $39.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,010.95 | 2023-2025 | |
| Galderma Laboratories, L.P. | $442.15 | 2022-2025 | |
| Allergan, INC. | $307.93 | 2021-2022 | |
| Smith+Nephew, INC. | $87.89 | 2021-2022 | |
| Kci USA, INC. | $59.66 | 2021-2022 | |
| Revance Therapeutics, INC. | $37.61 | 2025 | Daxxify |
| Bioventus LLC | $34.23 | 2022 | |
| Mentor Worldwide LLC | $32.33 | 2021 | |
| Merz North America, INC. | $23.38 | 2024 | |
| Organogenesis INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Winterhalter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.